Skip to main content
PMC home page
Thorax logoLink to Thorax
. 1999 Sep;54(9):757–761. doi: 10.1136/thx.54.9.757

Extended tumour necrosis factor/HLA-DR haplotypes and asthma in an Australian population sample

M Moffatt 1, A James 1, G Ryan 1, A Musk 1, W Cookson 1
PMCID: PMC1745569  PMID: 10456966

Abstract

BACKGROUND—Tumour necrosis factor (TNF) is a potent pro-inflammatory cytokine which is prominent in asthmatic airways. TNF shows genetic variations in secretion which are linked to polymorphisms in the TNF gene complex and the surrounding major histocompatibility (MHC) locus. These polymorphisms do not seem to be themselves functionally important. In these circumstances, the identification of disease associated haplotypes (combination of alleles on individual chromosomes) may narrow the search for polymorphisms which alter gene function.
METHODS—TNF-308, LTαNcoI, and HLA-DRB1 polymorphisms were investigated for association with asthma, bronchial responsiveness, and medication use in 1004 subjects in 230 families from a general population sample.
RESULTS—The common LTαNcoI*1/TNF-308*2/HLA-DRB1*03 haplotype, which was present in 11% of unrelated individuals, was weakly associated with asthma (OR = 1.38, p = 0.016, corrected for familial correlation). The rarer LTαNcoI*1/TNF-308*2/HLA-DRB1*02 haplotype, which was found in 0.6% of unrelated subjects, was more strongly associated with asthma (OR = 6.68, p = 0.002). This haplotype also showed association with bronchial hyperresponsiveness (OR = 21.9, p =0.0000) and the use of inhaled or oral steroids (OR 8.0, p = 0.04).
CONCLUSIONS—The results of this study show only two extended TNF/HLA-DR haplotypes to be associated with asthma. The search for functional alleles responsible for an increased risk of asthma should concentrate on the LTαNcoI*1/TNF-308*2/HLA-DRB1*02 haplotype.



Full Text

The Full Text of this article is available as a PDF (97.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beck H. P., Felger I., Barker M., Bugawan T., Genton B., Alexander N., Jazwinska E., Erlich H., Alpers M. Evidence of HLA class II association with antibody response against the malaria vaccine SPF66 in a naturally exposed population. Am J Trop Med Hyg. 1995 Sep;53(3):284–288. [PubMed] [Google Scholar]
  2. Broide D. H., Lotz M., Cuomo A. J., Coburn D. A., Federman E. C., Wasserman S. I. Cytokines in symptomatic asthma airways. J Allergy Clin Immunol. 1992 May;89(5):958–967. doi: 10.1016/0091-6749(92)90218-q. [DOI] [PubMed] [Google Scholar]
  3. Djukanović R., Roche W. R., Wilson J. W., Beasley C. R., Twentyman O. P., Howarth R. H., Holgate S. T. Mucosal inflammation in asthma. Am Rev Respir Dis. 1990 Aug;142(2):434–457. doi: 10.1164/ajrccm/142.2.434. [DOI] [PubMed] [Google Scholar]
  4. Dunham I., Sargent C. A., Trowsdale J., Campbell R. D. Molecular mapping of the human major histocompatibility complex by pulsed-field gel electrophoresis. Proc Natl Acad Sci U S A. 1987 Oct;84(20):7237–7241. doi: 10.1073/pnas.84.20.7237. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Farewell V. T., Dahlberg S. Some statistical methodology for the analysis of HLA data. Biometrics. 1984 Jun;40(2):547–560. [PubMed] [Google Scholar]
  6. George V. T., Elston R. C. Testing the association between polymorphic markers and quantitative traits in pedigrees. Genet Epidemiol. 1987;4(3):193–201. doi: 10.1002/gepi.1370040304. [DOI] [PubMed] [Google Scholar]
  7. Green P. M., Bentley D. R., Mibashan R. S., Nilsson I. M., Giannelli F. Molecular pathology of haemophilia B. EMBO J. 1989 Apr;8(4):1067–1072. doi: 10.1002/j.1460-2075.1989.tb03474.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Hill M. R., James A. L., Faux J. A., Ryan G., Hopkin J. M., le Söuef P., Musk A. W., Cookson W. O. Fc epsilon RI-beta polymorphism and risk of atopy in a general population sample. BMJ. 1995 Sep 23;311(7008):776–779. doi: 10.1136/bmj.311.7008.776. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hopper J. L., Jenkins M. A., Carlin J. B., Giles G. G. Increase in the self-reported prevalence of asthma and hay fever in adults over the last generation: a matched parent-offspring study. Aust J Public Health. 1995 Apr;19(2):120–124. doi: 10.1111/j.1753-6405.1995.tb00359.x. [DOI] [PubMed] [Google Scholar]
  10. Jacob C. O., Fronek Z., Lewis G. D., Koo M., Hansen J. A., McDevitt H. O. Heritable major histocompatibility complex class II-associated differences in production of tumor necrosis factor alpha: relevance to genetic predisposition to systemic lupus erythematosus. Proc Natl Acad Sci U S A. 1990 Feb;87(3):1233–1237. doi: 10.1073/pnas.87.3.1233. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Jorde L. B., Watkins W. S., Carlson M., Groden J., Albertsen H., Thliveris A., Leppert M. Linkage disequilibrium predicts physical distance in the adenomatous polyposis coli region. Am J Hum Genet. 1994 May;54(5):884–898. [PMC free article] [PubMed] [Google Scholar]
  12. Marsh D. G., Meyers D. A., Bias W. B. The epidemiology and genetics of atopic allergy. N Engl J Med. 1981 Dec 24;305(26):1551–1559. doi: 10.1056/NEJM198112243052603. [DOI] [PubMed] [Google Scholar]
  13. Messer G., Spengler U., Jung M. C., Honold G., Blömer K., Pape G. R., Riethmüller G., Weiss E. H. Polymorphic structure of the tumor necrosis factor (TNF) locus: an NcoI polymorphism in the first intron of the human TNF-beta gene correlates with a variant amino acid in position 26 and a reduced level of TNF-beta production. J Exp Med. 1991 Jan 1;173(1):209–219. doi: 10.1084/jem.173.1.209. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Moffatt M. F., Cookson W. O. Tumour necrosis factor haplotypes and asthma. Hum Mol Genet. 1997 Apr;6(4):551–554. doi: 10.1093/hmg/6.4.551. [DOI] [PubMed] [Google Scholar]
  15. Moffatt M. F., Schou C., Faux J. A., Cookson W. O. Germline TCR-A restriction of immunoglobulin E responses to allergen. Immunogenetics. 1997;46(3):226–230. doi: 10.1007/s002510050266. [DOI] [PubMed] [Google Scholar]
  16. Nedospasov S. A., Shakhov A. N., Turetskaia R. L., Mett V. A., Georgiev G. P. Molekuliarnoe klonirovanie genov cheloveka, kodiruiushchikh faktory nekroza opukholei: tandemnoe raspolozhenie al'fa- i beta-genov v korotkom segmente (6 tys. par nukleotidov) genoma cheloveka. Dokl Akad Nauk SSSR. 1985;285(6):1487–1490. [PubMed] [Google Scholar]
  17. O'Connor G. T., Weiss S. T. Clinical and symptom measures. Am J Respir Crit Care Med. 1994 Feb;149(2 Pt 2):S21–S30. doi: 10.1164/ajrccm/149.2_Pt_2.S21. [DOI] [PubMed] [Google Scholar]
  18. O'Connor G., Sparrow D., Taylor D., Segal M., Weiss S. Analysis of dose-response curves to methacholine. An approach suitable for population studies. Am Rev Respir Dis. 1987 Dec;136(6):1412–1417. doi: 10.1164/ajrccm/136.6.1412. [DOI] [PubMed] [Google Scholar]
  19. Peat J. K., Haby M., Spijker J., Berry G., Woolcock A. J. Prevalence of asthma in adults in Busselton, Western Australia. BMJ. 1992 Nov 28;305(6865):1326–1329. doi: 10.1136/bmj.305.6865.1326. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Peat J. K., Salome C. M., Berry G., Woolcock A. J. Relation of dose-response slope to respiratory symptoms and lung function in a population study of adults living in Busselton, Western Australia. Am Rev Respir Dis. 1992 Oct;146(4):860–865. doi: 10.1164/ajrccm/146.4.860. [DOI] [PubMed] [Google Scholar]
  21. Peat J. K., Salome C. M., Berry G., Woolcock A. J. Relation of dose-response slope to respiratory symptoms in a population of Australian schoolchildren. Am Rev Respir Dis. 1991 Sep;144(3 Pt 1):663–667. doi: 10.1164/ajrccm/144.3_Pt_1.663. [DOI] [PubMed] [Google Scholar]
  22. Powrie F., Menon S., Coffman R. L. Interleukin-4 and interleukin-10 synergize to inhibit cell-mediated immunity in vivo. Eur J Immunol. 1993 Nov;23(11):3043–3049. doi: 10.1002/eji.1830231147. [DOI] [PubMed] [Google Scholar]
  23. Renzetti L. M., Paciorek P. M., Tannu S. A., Rinaldi N. C., Tocker J. E., Wasserman M. A., Gater P. R. Pharmacological evidence for tumor necrosis factor as a mediator of allergic inflammation in the airways. J Pharmacol Exp Ther. 1996 Aug;278(2):847–853. [PubMed] [Google Scholar]
  24. Strachan D. P., Anderson H. R., Limb E. S., O'Neill A., Wells N. A national survey of asthma prevalence, severity, and treatment in Great Britain. Arch Dis Child. 1994 Mar;70(3):174–178. doi: 10.1136/adc.70.3.174. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Virchow J. C., Jr, Walker C., Hafner D., Kortsik C., Werner P., Matthys H., Kroegel C. T cells and cytokines in bronchoalveolar lavage fluid after segmental allergen provocation in atopic asthma. Am J Respir Crit Care Med. 1995 Apr;151(4):960–968. doi: 10.1164/ajrccm/151.4.960. [DOI] [PubMed] [Google Scholar]
  26. Woolcock A. J., Peat J. K., Salome C. M., Yan K., Anderson S. D., Schoeffel R. E., McCowage G., Killalea T. Prevalence of bronchial hyperresponsiveness and asthma in a rural adult population. Thorax. 1987 May;42(5):361–368. doi: 10.1136/thx.42.5.361. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Wordsworth B. P., Allsopp C. E., Young R. P., Bell J. I. HLA-DR typing using DNA amplification by the polymerase chain reaction and sequential hybridization to sequence-specific oligonucleotide probes. Immunogenetics. 1990;32(6):413–418. doi: 10.1007/BF00241635. [DOI] [PubMed] [Google Scholar]
  28. Yan K., Salome C., Woolcock A. J. Rapid method for measurement of bronchial responsiveness. Thorax. 1983 Oct;38(10):760–765. doi: 10.1136/thx.38.10.760. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Young R. P., Dekker J. W., Wordsworth B. P., Schou C., Pile K. D., Matthiesen F., Rosenberg W. M., Bell J. I., Hopkin J. M., Cookson W. O. HLA-DR and HLA-DP genotypes and immunoglobulin E responses to common major allergens. Clin Exp Allergy. 1994 May;24(5):431–439. doi: 10.1111/j.1365-2222.1994.tb00931.x. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES